Skip to content
The Kids Research Institute Australia logo
Donate

No results yet

Search

Showing results for "Au"

Data Analyst - Genome Nexus

This position will develop and support bioinformatics analysis and run pipelines required for clinical and research use of big data.

Indigenous Postdoctoral Researcher END RHD CRE

End Rheumatic Heart Disease Centre of Research Excellence seeks an Indigenous Postdoctoral Researcher

Clinical Lead – Autism Clinical Research Centre

The newly created centre will focus on infants and kids showing early signs of autism, other developmental delays or have a diagnosis of autism.

Senior Research Fellow Making FASD History

Work with established research projects in FASD within a broad strategy of work Making FASD History and secure new funding and collaborations.

Research

Folate Status and Neural Tube Defects in Aboriginal Australians: The Success of Mandatory Fortification in Reducing a Health Disparity

Mandatory flour fortification with folic acid in 2009, led to further reductions in overall neural tube defects

Research

Intact spontaneous emotional expressivity to non-facial but not facial stimuli in schizophrenia: An electromyographic study

The results indicate that schizophrenia is marked by a disruption in rapid facial responding to facial expressions, but intact responding to non-facial emotional stimuli

Research

Maternal serum unmetabolized folic acid concentration following multivitamin and mineral supplementation with or without folic acid after 12 weeks gestation: A randomized controlled trial

Pregnant women are advised to take folic acid (FA) supplements before conception and during the first trimester of pregnancy. Many women continue FA supplementation throughout pregnancy, and concerns have been raised about associations between excessive FA intake and adverse maternal and child health outcomes.

Research

EphA3-targeted chimeric antigen receptor T cells are effective in glioma and generate curative memory T cell responses

High-grade gliomas including glioblastoma (GBM) and diffuse midline gliomas (DMG) represent the most lethal and aggressive brain cancers where current treatment modalities offer limited efficacy. Chimeric antigen receptor (CAR) T cell therapies have emerged as a promising strategy, boasting tumor-specific targeting and the unique ability to penetrate the blood-brain barrier.